OPEN TEXT CORPOTEX

Market cap
$8.5B
P/E ratio
Jun 30,
2010
Jun 30,
2011
Jun 30,
2012
Jun 30,
2013
Jun 30,
2014
Jun 30,
2015
Jun 30,
2016
Jun 30,
2017
Jun 30,
2018
Jun 30,
2019
Jun 30,
2020
Jun 30,
2021
Jun 30,
2022
Jun 30,
2023
Jun 30,
2024
Jun 30,
2025
Net income----2182342841,026242286234311397151465436
Other Depreciation and Amortization----------515521504657808641
Share-based compensation expense10111816202226312827305270130140105
Pension expense011135544567791415
Amortization of Debt Issuance Costs1122355554555172522
Write-off of right of use assets----------37-1810209
Loss on extinguishment of debt-------------27-8-56-
Gain (adjustments to gain) on AMC Divestiture--------------429-4
Loss on sale and write down of property and equipment, net-0-0-0-0-0-1-1-1-2-9-10-3-0-2-4-3
Deferred taxes-24-18-79-6-31-15-54-87190475173-36-150-142-139
Share in net (income) loss of equity investees-------661496359-23-180
Changes in derivative instruments1-------------1293-44
Accounts receivable-25-0-5-1817-43-912723-76-84-61-82-169-109-80
Contract assets---------384039387495136
Prepaid expenses and other current assets1-22-4-114-08717-38142328-42
Income taxes------6-2-3127-35-1413515112-247
Accounts payable and accrued liabilities-11-21-18-41-36-23-653-92-223126-24-127-66-23
Deferred revenue--------36-22539-5-128-434
Other assets233-2065-223-20-1-12-1711-2515
Operating lease assets and liabilities, net----------1274282115
Net cash provided by operating activities180223266319417523526439710876955876982779968831
Additions of property and equipment193726234277708010564736493124159143
Purchase of Micro Focus, net of cash acquired-------------5,6589-
Proceeds (adjustments to proceeds) from AMC Divestiture----------------12
Settlement of derivative instruments---------------10
Realized gain on financial instruments-------------131--
Proceeds from Hedge, Investing Activities--------------45
Other investing activities---------171454110-7
Net cash provided by (used in) investing activities-110-287-282-374-1,153-398-361-2,191-444-465-1,469-69-971-5,6512,055-154
Proceeds from Issuance of Common Stock10122116251520367658678067396735
Proceeds from Issuance of Long-Term Debt-------2571,200-3,150-1,5004,927--
Repayment of long-term debt and Revolver3434931465308581,150101,7146108602032,56836
Debt issuance costs1010-1718774022-177841
Net change in transition services agreement obligation---------------1515
Repurchase of Common Shares141211-110---2712-177-150413
Purchase of treasury stock-----------651122253131
Payments of dividends to shareholders---18758899121146169189211238260267272
Other financing activities--------------1-1-2
Net cash provided by (used in) financing activities-7-3303-31688171430910-24-1481,269-9251384,403-2,962-835
Foreign exchange gain (loss) on cash held in foreign currencies----------4-030-637-1233
Increase (decrease) in cash, cash equivalents and restricted cash during the year---------260754-8786-46249-125